Literature DB >> 165252

Mechanism of avian estrogen-induced hypertriglyceridemia: evidence for overproduction of triglyceride.

D J Kudzma, F St Claire, L DeLallo, S J Friedberg.   

Abstract

Relying on methods other than the determination of turnover rate of triglyceride from the curve of plasma triglyceride radioactivity after administration of labeled precursor, we have confirmed that the endogenous hypertriglyceridemia induced by estrogenization of the chick is accompanied by increased production of triglyceride. Chicks estrogenized with diethylstilbestrol became grossly hypertriglyceridemic and had elevated levels of plasma free fatty acid. Within 5 min of administration of labeled palmitate, estrogenized hypertriglyceridemic birds converted approximately 10 times more plasma free fatty acid to hepatic triglyceride than did controls. In addition, 2 hr after intraperitoneal injection of [14-C]acetate or [U-14-C]glucose, the specific activity of very low density lipoprotein triglyceride (VLDL-TG) of estrogenized birds reached or exceeded that of the untreated controls, and the rapid enrichment of the vastly expanded plasma VLDL-TG pool with labeled triglyceride further indicated that increased production of triglyceride occurs with estrogenization. Furthermore, [14-C]acetate incorporation into VLDL-TG was calculated to be 1.6 and 6.6% of the injected dose in estrogenized birds compared with 0.1 and 0.2% in untreated birds. Increased production of plasma VLDL-TG was confirmed by a kinetic study of VLDL-TG metabolism, employing reinjected, endogenously prepared [14-C]triglyceride-labeled VLDL. The fractional turnover rate of VLDL-TG in estrogenized hypertriglyceridemic birds was substantially less than that in untreated controls (0.32 plus or minus 0.03 vs 0.71 plus or minus 0.03/hr), but the total turnover rate was nearly 50 times greater (244 plus or minus 52 vs. 5 plus or minus 1 mg/hr).

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 165252

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

1.  Plasma triacylglycerol turnover in rats using labeled glycerol.

Authors:  N Baker
Journal:  Lipids       Date:  1984-02       Impact factor: 1.880

2.  Estradiol is a potent inhibitor of the hypotriglyceridemic effect of levonorgestrel in female rats.

Authors:  E H Taves; B M Wolfe
Journal:  Lipids       Date:  1989-07       Impact factor: 1.880

3.  Effects of ethynyloestradiol on the metabolism of [1-14C]oleate by perfused livers and hepatocytes from female rats.

Authors:  I Weinstein; C Soler-Argilaga; H V Werner; M Heimberg
Journal:  Biochem J       Date:  1979-05-15       Impact factor: 3.857

4.  Sex differences in long chain fatty acid utilization and fatty acid binding protein concentration in rat liver.

Authors:  R K Ockner; D A Burnett; N Lysenko; J A Manning
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

5.  Sex steroid modulation of fatty acid utilization and fatty acid binding protein concentration in rat liver.

Authors:  R K Ockner; N Lysenko; J A Manning; S E Monroe; D A Burnett
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

6.  Increases in serum sphingomyelin by 17 beta-estradiol.

Authors:  A H Merrill; E Wang; W S Innis; R Mullins
Journal:  Lipids       Date:  1985-04       Impact factor: 1.880

7.  Effects of 17β-estradiol and starvation on trout plasma lipoproteins.

Authors:  C Wallaert; P J Babin
Journal:  Lipids       Date:  1992-12       Impact factor: 1.880

8.  Changes in plasma lipids, lipoproteins, triglyceride secretion and removal in chicks with estrogen implants.

Authors:  J R Park; B H Cho
Journal:  Lipids       Date:  1988-04       Impact factor: 1.880

9.  Lipogenesis and the synthesis and secretion of very low density lipoprotein by avian liver cells in nonproliferating monolayer culture. Hormonal effects.

Authors:  D M Tarlow; P A Watkins; R E Reed; R S Miller; E E Zwergel; M D Lane
Journal:  J Cell Biol       Date:  1977-05       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.